Literature DB >> 25546761

Solid organ transplantation: hypogammaglobulinaemia and infectious complications after solid organ transplantation.

D F Florescu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546761      PMCID： PMC4285490          DOI： 10.1111/cei.12510

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

1.  The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study.

Authors:  Mohamad H Yamani; Robin Avery; Steven D Mawhorter; Ann McNeill; Daniel Cook; Norman B Ratliff; David Pelegrin; Phyllis Colosimo; Karen Kiefer; Kristin Ludrosky; Robert Hobbs; David Taylor; Tiffany Buda; Michael Yeager; James B Young; Nicholas Smedira; Randall C Starling
Journal:  J Heart Lung Transplant       Date:  2005-11       Impact factor: 10.247

2.  Subcutaneous IgG replacement therapy is safe and well tolerated in lung transplant recipients.

Authors:  T Shankar; J Gribowicz; M Crespo; F P Silveira; J Pilewski; A A Petrov
Journal:  Int Immunopharmacol       Date:  2013-03-15       Impact factor: 4.932

3.  The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency.

Authors:  James A Nathan; Linda D Sharples; Andrew R Exley; Pasupathy Sivasothy; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2005-10       Impact factor: 10.247

4.  Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.

Authors:  J Carbone; E Sarmiento; N Del Pozo; J J Rodriguez-Molina; J Navarro; J Fernandez-Yañez; J Palomo; A Villa; P Muñoz; E Fernandez-Cruz
Journal:  Clin Transplant       Date:  2012 May-Jun       Impact factor: 2.863

5.  Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes.

Authors:  M H Yamani; R Avery; S Mawhorter; J B Young; A McNeill; D J Cook; N B Ratiff; P McCarthy; R C Starling
Journal:  Transpl Infect Dis       Date:  2001       Impact factor: 2.228

6.  The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.

Authors:  J Carbone; E Sarmiento; J Palomo; J Fernandez-Yañez; P Muñoz; E Bouza; J Rodríguez-Molina; N Lanio; E Fernandez-Cruz
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

7.  Incidence, timing, and significance of early hypogammaglobulinemia after intestinal transplantation.

Authors:  Douglas G Farmer; Omar M Kattan; Laura J Wozniak; Elizabeth Marcus; Susan Ponthieux; Villy Hwang; Ronald W Busuttil; Suzanne V McDiarmid; Robert S Venick
Journal:  Transplantation       Date:  2013-05-15       Impact factor: 4.939

8.  What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.

Authors:  D F Florescu; A C Kalil; F Qiu; C M Schmidt; U Sandkovsky
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086

Review 9.  Hypogammaglobulinemia and infection risk in solid organ transplant recipients.

Authors:  Steven Mawhorter; Mohamad H Yamani
Journal:  Curr Opin Organ Transplant       Date:  2008-12       Impact factor: 2.640

10.  Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine.

Authors:  K Keven; M Sahin; S Kutlay; S Sengul; S Erturk; S Ersoz; B Erbay
Journal:  Transpl Infect Dis       Date:  2003-12       Impact factor: 2.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.